The video explains how Ozempic and Wegovy differ in approvals, dosing, and coverage, shaping access to diabetes and obesity care. Both contain semaglutide, a GLP-1 receptor agonist; Ozempic was ...

Glucagon-like peptide-1 receptor agonists (GLP-1s) have become well known for their significant role as an aid in weight loss ...

Corrections: This story was updated to clarify the findings of clinical trials and out-of-pocket cost information. As the GLP-1 weight-loss drug market continues to grow, consumers weary of needles ...

TheDoseReport.com Releases Analysis: Which GLP-1 is Best? Semaglutide and Tirzepatide Compared. Confused about GLP-1 options for weight management? Take our quick quiz to find out which GLP-1 is best ...

Individuals with atrial fibrillation (Afib), or irregular heart rhythm, are at increased risk of stroke, chronic kidney ...

GLP-1 receptor agonists may confer neuroprotection via reduced neuroinflammation, inhibited apoptosis, and vasodilatory effects that enhance cerebral perfusion through cAMP and VEGF-related pathways.

You don’t need me to tell you about the widespread popularity of GLP-1 drugs. We’ve reached a point where anyone who loses a ...

About The Study: This randomized clinical trial found that continuing glucagon-like peptide-1 (GLP-1) or glucose-dependent insulinotropic polypeptide (GIP) agonist in the preprocedural period ...

The "TikTok Medical Group" has stirred the viral waters around biohacking male infertility. GLP-1 receptor agonists are ...

GLP-1 receptor agonists may lower the likelihood of psychiatric treatment intensification in patients with type 2 diabetes and depression.

After one year, people taking a GLP-1 drug had better outcomes than those taking an SGLT-2 drug. Specifically, they were 36% less likely to die from any cause, 12% less likely to be hospitalized, 22% ...